Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Semler Scientific
Santa Clara, California, United Statessemlerscientific.com ↗
- Ownership
- Public · SMLR
- Employees
- ~79
- Development stage
- Commercial
01
Overview
Semler Scientific's flagship product QuantaFlo® is FDA-cleared and commercially available for point-of-care detection of peripheral arterial disease. The company also markets software for glycemic management in diabetes and has invested in technologies for inpatient glucose control and early Alzheimer's diagnosis. Clinical results published in peer-reviewed journals show that QuantaFlo can detect undiagnosed PAD in 31.6% of patients aged 65+; the device supports risk stratification for major adverse cardiovascular events[8].
- Therapeutic areas
- EndocrinologyCardiovascularNeurology
- Modalities
- DeviceSoftwareDiagnostic test
- Industry
- Physiological Monitoring
02
Partnerships
Mellitus Health – exclusive marketing/distribution agreement for Insulin Insights™[7]Investment/partnership with Monarch Medical Technologies[7]Investment/partnership with SynapsDX[7]
03
Financials
- Market cap
- $310.7M
- Total revenue
- $7.5M
- Enterprise value
- $417M
Beyond the preview
Go deeper on Semler Scientific.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Semler Scientific.